Clariane Past Earnings Performance
Past criteria checks 0/6
Clariane's earnings have been declining at an average annual rate of -25.5%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 7.4% per year. Clariane's return on equity is 1%, and it has net margins of 0.6%.
Key information
-25.5%
Earnings growth rate
-33.5%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 7.4% |
| Return on equity | 1.0% |
| Net Margin | 0.6% |
| Next Earnings Update | 28 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Clariane makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 4,735 | 28 | 509 | 0 |
| 31 Mar 23 | 4,587 | 32 | 483 | 0 |
| 31 Dec 22 | 4,438 | 36 | 458 | 0 |
| 30 Jun 22 | 4,288 | 85 | 439 | 0 |
| 31 Mar 22 | 4,212 | 92 | 434 | 0 |
| 31 Dec 21 | 4,137 | 100 | 430 | 0 |
| 30 Sep 21 | 4,047 | 76 | 404 | 0 |
| 30 Jun 21 | 3,941 | 60 | 425 | 0 |
| 31 Mar 21 | 3,857 | 50 | 431 | 0 |
| 31 Dec 20 | 3,773 | 39 | 437 | 0 |
| 30 Sep 20 | 3,728 | 57 | 446 | 0 |
| 30 Jun 20 | 3,683 | 74 | 456 | 0 |
| 31 Mar 20 | 3,648 | 94 | 452 | 0 |
| 31 Dec 19 | 3,613 | 115 | 449 | 0 |
| 30 Sep 19 | 3,542 | 117 | 528 | 0 |
| 30 Jun 19 | 3,471 | 119 | 607 | 0 |
| 31 Mar 19 | 3,404 | 121 | 686 | 0 |
| 31 Dec 18 | 3,336 | 123 | 765 | 0 |
| 30 Sep 18 | 3,280 | 152 | 755 | 0 |
| 30 Jun 18 | 3,224 | 180 | 744 | 0 |
| 31 Mar 18 | 3,177 | 172 | 739 | 0 |
| 31 Dec 17 | 3,131 | 163 | 735 | 0 |
| 30 Sep 17 | 3,091 | 150 | 736 | 0 |
| 30 Jun 17 | 3,052 | 137 | 738 | 0 |
| 31 Mar 17 | 3,017 | 134 | 733 | 0 |
| 31 Dec 16 | 2,981 | 131 | 728 | 0 |
| 30 Sep 16 | 2,880 | 87 | 706 | 0 |
| 30 Jun 16 | 2,779 | 42 | 684 | 0 |
| 31 Mar 16 | 2,676 | 50 | 674 | 0 |
| 31 Dec 15 | 2,573 | 59 | 664 | 0 |
| 30 Sep 15 | 2,553 | 77 | 664 | 0 |
| 30 Jun 15 | 2,533 | 95 | 664 | 0 |
| 31 Mar 15 | 2,378 | 78 | 631 | 0 |
| 31 Dec 14 | 2,222 | 61 | 597 | 0 |
| 30 Sep 14 | 1,938 | 44 | 526 | 0 |
| 30 Jun 14 | 1,654 | 27 | 455 | 0 |
| 31 Mar 14 | 1,505 | 28 | 423 | 0 |
| 31 Dec 13 | 1,356 | 29 | 391 | 0 |
| 30 Sep 13 | 1,286 | 29 | 378 | 0 |
| 30 Jun 13 | 1,216 | 29 | 364 | 0 |
| 31 Mar 13 | 1,162 | 26 | 345 | 0 |
Quality Earnings: CLARIP has a large one-off loss of €87.4M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: CLARIP's current net profit margins (0.6%) are lower than last year (2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLARIP's earnings have declined by 25.5% per year over the past 5 years.
Accelerating Growth: CLARIP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CLARIP had negative earnings growth (-66.9%) over the past year, making it difficult to compare to the Healthcare industry average (3.8%).
Return on Equity
High ROE: CLARIP's Return on Equity (1%) is considered low.